tiprankstipranks
Vaxxinity Inc (VAXX)
:VAXX
US Market
Holding VAXX?
Track your performance easily

Vaxxinity Inc (VAXX) Stock Price & Analysis

140 Followers

VAXX Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

79.90%0.06%0.03%20.01%
79.90%
Insiders
0.06%
Mutual Funds
0.03% Other Institutional Investors
20.01% Public Companies and
Individual Investors

VAXX FAQ

What was Vaxxinity Inc’s price range in the past 12 months?
Vaxxinity Inc lowest stock price was $0.00 and its highest was $1.05 in the past 12 months.
    What is Vaxxinity Inc’s market cap?
    Vaxxinity Inc’s market cap is $56.26K.
      When is Vaxxinity Inc’s upcoming earnings report date?
      Vaxxinity Inc’s upcoming earnings report date is Apr 01, 2025 which is in 71 days.
        How were Vaxxinity Inc’s earnings last quarter?
        Currently, no data Available
        Is Vaxxinity Inc overvalued?
        According to Wall Street analysts Vaxxinity Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Vaxxinity Inc pay dividends?
          Vaxxinity Inc does not currently pay dividends.
          What is Vaxxinity Inc’s EPS estimate?
          Vaxxinity Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Vaxxinity Inc have?
          Vaxxinity Inc has 126,784,680 shares outstanding.
            What happened to Vaxxinity Inc’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Vaxxinity Inc?
            Currently, no hedge funds are holding shares in VAXX
            ---

            Company Description

            Vaxxinity Inc

            Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            AlloVir
            SELLAS Life Sciences Group
            BioVie
            Anavex Life Sciences
            Cyclo Therapeutics
            AstraZeneca
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis